Despite a common perception that ART leads to moredrug discontinuations in HIV/HCV co-infected patients, especially forcertain compounds, as compared to HIV mono-infected, it remainsunclear whether co-infection leads to higher frequency of treatmentchanges for a given time in care.
Are HIV/HCV co-infected patients more likely to experience multiple lines of ART than HIV mono-infected patients? Results from the ICONA Foundation Study
G. Nunnari;
2016-01-01
Abstract
Despite a common perception that ART leads to moredrug discontinuations in HIV/HCV co-infected patients, especially forcertain compounds, as compared to HIV mono-infected, it remainsunclear whether co-infection leads to higher frequency of treatmentchanges for a given time in care.File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
HIV.pdf
solo gestori archivio
Tipologia:
Versione Editoriale (PDF)
Licenza:
NON PUBBLICO - Accesso privato/ristretto
Dimensione
381.58 kB
Formato
Adobe PDF
|
381.58 kB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
